Sources Sought Single Donor, Type Specific Tender in USA - 142252556

Procurement Summary

Country: USA

Summary: Sources Sought Notice for Single Donor, Type Specific, Universal Freezedried Plasma Activities for Commercial Sustainability

Deadline: 02 Jun 2026

Posting Date: 29 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 142252556

Document Ref. No.: HT942726RE014

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

This Sources Sought Notice (SSN) is for market research, information, and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the Defense Health Agency Contracting Activity (DHACA) Medical Research & Development Contracting Division 2 or the Defense Health Agency (DHA) Portfolio Acquisition Executive (PAE) Medical Products.
This SSN is being issued by DHACA on behalf of PAE Medical Products and is seeking sources to develop, license, and sustain a Freeze-Dried Plasma (FDP) product in accordance with the Department of War (DoW) Acquisition System, U.S. Food and Drug Administration (FDA) regulations and guidelines, and industry best practices. In direct support of the PAE-s product development effort, the Government is seeking to obtain Product Lifecycle Management (PLM) activities necessary to sustain the commercial viability of a FDP product.
If capable sources are not identified through this notice, then DHACA intends to execute an award on a sole source basis under the authority of the Revolutionary FAR Overhaul (RFO) FAR 6.103-1 to Vascular Solutions LLC, 6464 Sycamore CT N, Maple Grove, Minnesota, 55369-6032 (a subsidiary of Teleflex LLC).
Vascular Solutions is uniquely positioned to execute the necessary PLM activities required to sustain the commercial viability of a FDP product. Vascular Solutions re-submitted FDP Biologics License Application (BLA) to the FDA and continues to complete the required activities as requested by the FDA during Pre-Approval Inspection and BLA review. Vascular Solutions will be the regulatory sponsor of the BLA and will manufacture, market, and distribute the Single Donor, Type Specific, Universal FDP product. There are no other FDA approved Dried Plasma products available. Vascular Solutions- FDP product is the only Single Donor, Type Specific, Universal product with a BLA in review by the FDA. If a contract was awarded on a competitive basis to a contractor other than Va...
Notice ID: ht942726re014

Department/Ind. Agency: dept of defense

Sub-tier: defense health agency (dha)

Office: defense health agency

Product Service Code: an13 - health r&d services; health care services; experimental development

NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Inactive Dates: jun 08, 2026

Inactive Policy: manual

Documents

 Tender Notice